Загрузка...
Prevalence of Established Cardiovascular Disease in Patients with Type 2 Diabetes Mellitus in the UK
INTRODUCTION: The results of recently completed cardiovascular outcomes trials in patients with type 2 diabetes mellitus (T2DM) suggest that sodium-glucose cotransporter-2 (SGLT2) inhibitors and glucagon-like peptide (GLP) 1 receptor agonists have enhanced cardioprotective properties in patients wit...
Сохранить в:
| Опубликовано в: : | Diabetes Ther |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer Healthcare
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6848348/ https://ncbi.nlm.nih.gov/pubmed/31583647 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-019-00698-9 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|